| Cancer-Associated Mutations in Endometriosis without Cancer | New England Journal of Medicine | 2017 | 310 |
| Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer | Cancer | 2017 | 267 |
| Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer | JAMA Oncology | 2017 | 152 |
| Long-Term Responders on Olaparib Maintenance in High-Grade Serous Ovarian Cancer: Clinical and Molecular Characterization | Clinical Cancer Research | 2017 | 83 |
| BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphology | Modern Pathology | 2017 | 78 |
| Uterine Inflammatory Myofibroblastic Tumors Frequently Harbor ALK Fusions With IGFBP5 and THBS1 | American Journal of Surgical Pathology | 2017 | 71 |
| Reappraisal of TDP-43 pathology in FTLD-U subtypes | Acta Neuropathologica | 2017 | 66 |
| Successful targeting of the NRG1 pathway indicates novel treatment strategy for metastatic cancer | Annals of Oncology | 2017 | 64 |
| Human papillomavirus (HPV)-independent vulvar squamous cell carcinoma has a worse prognosis than HPV-associated disease: a retrospective cohort study | Histopathology | 2017 | 56 |
| Interobserver Agreement in Endometrial Carcinoma Histotype Diagnosis Varies Depending on The Cancer Genome Atlas (TCGA)-based Molecular Subgroup | American Journal of Surgical Pathology | 2017 | 56 |
| Clear cell and endometrioid carcinomas: are their differences attributable to distinct cells of origin? | Journal of Pathology | 2017 | 50 |
| High-grade serous carcinoma of tubo-ovarian origin: recent developments | Histopathology | 2017 | 48 |
| GATA3 Immunohistochemistry for Distinguishing Sarcomatoid and Desmoplastic Mesothelioma From Sarcomatoid Carcinoma of the Lung | American Journal of Surgical Pathology | 2017 | 43 |
| Cytologic features and clinical implications of undifferentiated carcinoma with osteoclastic giant cells of the pancreas: An analysis of 15 cases | Cancer Cytopathology | 2017 | 29 |
| Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine. Part 3: Technical Validation of Immunohistochemistry (IHC) Assays in Clinical IHC Laboratories | Applied Immunohistochemistry and Molecular Morphology | 2017 | 28 |
| Clinical and neuropathological features of ALS/FTD with TIA1 mutations | Acta Neuropathologica Communications | 2017 | 27 |
| Frequent Mismatch Repair Protein Deficiency in Mixed Endometrioid and Clear Cell Carcinoma of the Endometrium | International Journal of Gynecological Pathology | 2017 | 25 |
| The Fallopian Tube Origin and Primary Site Assignment in Extrauterine High-grade Serous Carcinoma: Findings of a Survey of Pathologists and Clinicians | International Journal of Gynecological Pathology | 2017 | 25 |
| Programmed cell death ligand 1 cut-point is associated with reduced disease specific survival in resected pancreatic ductal adenocarcinoma | BMC Cancer | 2017 | 25 |
| Loss of BRCA1-associated protein 1 (BAP1) expression is rare in non-small cell lung cancer | Human Pathology | 2017 | 25 |
| Enterobacter cloacae Complex Isolates Harboring or -Type Class A Carbapenemase Genes on Novel Chromosomal Integrative Elements and Plasmids | Antimicrobial Agents and Chemotherapy | 2017 | 22 |
| Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine: Part 1: Fit-for-Purpose Approach to Classification of Clinical Immunohistochemistry Biomarkers | Applied Immunohistochemistry and Molecular Morphology | 2017 | 20 |
| Large-scale gene network analysis reveals the significance of extracellular matrix pathway and homeobox genes in acute myeloid leukemia: an introduction to the Pigengene package and its applications | BMC Medical Genomics | 2017 | 20 |
| FOXL2 402C>G Mutation Can Be Identified in the Circulating Tumor DNA of Patients with Adult-Type Granulosa Cell Tumor | Journal of Molecular Diagnostics | 2017 | 19 |
| A comparison of p53 and WT1 immunohistochemical expression patterns in tubo-ovarian high-grade serous carcinoma before and after neoadjuvant chemotherapy | Histopathology | 2017 | 19 |
